- Home
- QGEN vs RVTY Comparison
QGEN vs RVTY Comparison
Compare QGEN & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- RVTY
- Stock Information
- Founded
- QGEN 1986
- RVTY 1937
- Country
- QGEN Netherlands
- RVTY United States
- Employees
- QGEN N/A
- RVTY N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- QGEN Health Care
- RVTY Industrials
- Exchange
- QGEN Nasdaq
- RVTY Nasdaq
- Market Cap
- QGEN 10.3B
- RVTY 9.8B
- IPO Year
- QGEN 1996
- RVTY N/A
- Fundamental
- Price
- QGEN $45.84
- RVTY $87.13
- Analyst Decision
- QGEN Buy
- RVTY Buy
- Analyst Count
- QGEN 8
- RVTY 13
- Target Price
- QGEN $51.01
- RVTY $120.08
- AVG Volume (30 Days)
- QGEN 1.3M
- RVTY 1.2M
- Earning Date
- QGEN 11-05-2025
- RVTY 11-03-2025
- Dividend Yield
- QGEN 3.32%
- RVTY 0.33%
- EPS Growth
- QGEN 405.09
- RVTY 72.56
- EPS
- QGEN 1.69
- RVTY 2.37
- Revenue
- QGEN $2,040,067,000.00
- RVTY $2,798,467,000.00
- Revenue This Year
- QGEN $7.22
- RVTY $5.55
- Revenue Next Year
- QGEN $5.66
- RVTY $4.26
- P/E Ratio
- QGEN $26.93
- RVTY $36.06
- Revenue Growth
- QGEN 5.15
- RVTY 3.33
- 52 Week Low
- QGEN $37.63
- RVTY $81.36
- 52 Week High
- QGEN $51.88
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- QGEN 39.86
- RVTY 49.07
- Support Level
- QGEN $45.18
- RVTY $81.69
- Resistance Level
- QGEN $46.18
- RVTY $88.49
- Average True Range (ATR)
- QGEN 0.67
- RVTY 2.74
- MACD
- QGEN -0.12
- RVTY 0.19
- Stochastic Oscillator
- QGEN 26.69
- RVTY 63.29
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.